Keep up with the latest happenings in Erba

Increasing footprints through new installations globally

Date : 11 Jan, 2022

Biospectrum, January 2022: “As we step into 2022, we pledge to offer newer and better technologies to reduce the incidence of other infectious diseases. We will continue to provide unmatched services to customers with our largest team of sales and service experts in the Indian IVD Industry, thus continuing our journey of making India a Healthy and Happy country. On the global front too, we will continue to increase our footprint through new installations, as we reach out to laboratories and hospitals, especially in the emerging markets. By 2023, Transasia’s R&D labs in France, UK, US, Austria and India will launch over 10 state-of-the-art analyzers in CLIA, molecular, high-end hematology, AI and LIS. Also in the offing is a ‘Total Lab Automation’solution aimed at mid and large size laboratories. All these will make Erba-Transasia among the top five companies globally to have Total Solutions in Laboratory Diagnostics.”

  • Suresh Vazirani

Founder Chairman
Erba-Transasia Group